Brazilian guidelines for the clinical management of paracoccidioidomycosis
- PMID: 28746570
- DOI: 10.1590/0037-8682-0230-2017
Brazilian guidelines for the clinical management of paracoccidioidomycosis
Erratum in
-
Erratum: Brazilian guidelines for the clinical management of paracoccidioidomycosis.Rev Soc Bras Med Trop. 2017 Sep-Oct;50(5):744. doi: 10.1590/0037-8682-0383-2017. Rev Soc Bras Med Trop. 2017. PMID: 29044299
-
Erratum.Rev Soc Bras Med Trop. 2017 Nov-Dec;50(6):879-880. doi: 10.1590/0037-8682-0470-2017. Rev Soc Bras Med Trop. 2017. PMID: 29340476
Abstract
Paracoccidioidomycosis is a systemic fungal disease occurring in Latin America that is associated with rural environments and agricultural activities. However, the incidence and prevalence of paracoccidiodomycosis is underestimated because of the lack of compulsory notification. If paracoccidiodomycosis is not diagnosed and treated early and adequately, the endemic fungal infection could result in serious sequelae. While the Paracoccidioides brasiliensis ( P. brasiliensis ) complex has been known to be the causal agent of paracoccidiodomycosis, a new species, Paracoccidioides lutzii ( P. lutzii ), has been reported in Rondônia, where the disease has reached epidemic levels, and in the Central West and Pará. Accurate diagnoses and availability of antigens that are reactive with the patients' sera remain significant challenges. Therefore, the present guidelines aims to update the first Brazilian consensus on paracoccidioidomycosis by providing evidence-based recommendations for bedside patient management. This consensus summarizes etiological, ecoepidemiological, molecular epidemiological, and immunopathological data, with emphasis on clinical, microbiological, and serological diagnosis and management of clinical forms and sequelae, as well as in patients with comorbidities and immunosuppression. The consensus also includes discussion of outpatient treatments, severe disease forms, disease prevalence among special populations and resource-poor settings, a brief review of prevention and control measures, current challenges and recommendations.
Similar articles
-
[Brazilian guidelines for the clinical management of paracoccidioidomycosis].Epidemiol Serv Saude. 2018 Aug 16;27(spe):e0500001. doi: 10.5123/S1679-49742018000500001. Epidemiol Serv Saude. 2018. PMID: 30133688 Portuguese.
-
Animal Models and Antifungal Agents in Paracoccidioidomycosis: An Overview.Mycopathologia. 2017 Aug;182(7-8):633-643. doi: 10.1007/s11046-017-0130-z. Epub 2017 Mar 21. Mycopathologia. 2017. PMID: 28324244 Review.
-
Pulmonary paracoccidioidomycosis.Semin Respir Crit Care Med. 2011 Dec;32(6):764-74. doi: 10.1055/s-0031-1295724. Epub 2011 Dec 13. Semin Respir Crit Care Med. 2011. PMID: 22167404 Review.
-
Paracoccidioidomycosis manifested by sarcoidosis-like cutaneous lesions and caused by Paracoccidioides brasiliensis sensu stricto (S1a).An Bras Dermatol. 2018 Nov/Dec;93(6):902-904. doi: 10.1590/abd1806-4841.20188293. An Bras Dermatol. 2018. PMID: 30484542 Free PMC article.
-
Acute Paracoccidioidomycosis in a 40-Year-Old Man: A Case Report and Literature Review.Mycopathologia. 2017 Dec;182(11-12):1095-1099. doi: 10.1007/s11046-017-0196-7. Epub 2017 Sep 12. Mycopathologia. 2017. PMID: 28900882 Review.
Cited by
-
First report of paracoccidioidomycosis reactivation as a complication of immunosuppressive therapy for acute severe colitis in a caving enthusiast.BMJ Case Rep. 2020 Jul 2;13(7):e234125. doi: 10.1136/bcr-2019-234125. BMJ Case Rep. 2020. PMID: 32616533 Free PMC article.
-
Diagnosis of Human Endemic Mycoses Caused by Thermally Dimorphic Fungi: From Classical to Molecular Methods.J Fungi (Basel). 2024 Sep 6;10(9):637. doi: 10.3390/jof10090637. J Fungi (Basel). 2024. PMID: 39330397 Free PMC article. Review.
-
Destructive genital and oral ulcers in rural patients.JAAD Case Rep. 2021 Mar 26;11:127-129. doi: 10.1016/j.jdcr.2021.03.036. eCollection 2021 May. JAAD Case Rep. 2021. PMID: 33997212 Free PMC article. No abstract available.
-
Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model.J Fungi (Basel). 2020 Sep 2;6(3):160. doi: 10.3390/jof6030160. J Fungi (Basel). 2020. PMID: 32887256 Free PMC article.
-
Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis.J Fungi (Basel). 2019 Jul 18;5(3):64. doi: 10.3390/jof5030064. J Fungi (Basel). 2019. PMID: 31323746 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources